Isomorphic Labs

Summary active Updated May 13, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location London, United Kingdom
Founded 2021
Latest Stage Series B
Total Raised $2.7B+
Website https://www.isomorphiclabs.com/
Sector
biotech ai drug-discovery ai-research pharma deep-tech

Investors

Joshua Kushner Growth (2024)
Thrive Capital series-b (2026)

Founders

Demis Hassabis Founder

About

Isomorphic Labs is a London-based AI drug discovery company spun out of Google DeepMind in 2021 by Demis Hassabis 12. The company builds its discovery platform on AlphaFold-derived technology to predict protein structures and model molecular interactions, and is advancing drug-design programs across multiple therapeutic areas through its IsoDDE engine 1. The company has indicated it expects its first clinical trials by the end of 2026 12. The $2.1B Series B announced May 12, 2026 was led by Thrive Capital with existing backers Alphabet and GV continuing, and new investors MGX, Temasek, CapitalG, and the UK Sovereign AI Fund joining 123.

Funding History

Date Round Amount Lead Co-investors
2026-05-12 Series B $2.1B Thrive Capital Alphabet, GV, MGX, Temasek, CapitalG, UK Sovereign AI Fund 123

What Investors Say

No independently sourced investor quotes found at this time.

What Founders Say

The Isomorphic Labs team stated: “The company aims to apply its pioneering AI drug design engine (IsoDDE) to deliver biomedical breakthroughs and is advancing drug design programs across multiple therapeutic areas and drug modalities.” 1

Sources

  1. Isomorphic Labs, “Isomorphic Labs announces Series B investment round,” May 12, 2026. Accessed May 2026. https://www.isomorphiclabs.com/articles/isomorphic-labs-announces-series-b-investment-round↩↩↩↩↩↩

  2. PR Newswire, “Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine,” May 12, 2026. Accessed May 2026. https://www.prnewswire.com/news-releases/isomorphic-labs-secures-2-1-billion-funding-to-scale-its-ai-drug-design-engine-302769674.html↩↩↩↩

  3. Yahoo Finance, “Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery,” May 12, 2026. Accessed May 2026. https://finance.yahoo.com/sectors/healthcare/articles/google-backed-isomorphic-raises-2-152155056.html↩↩